ReviewAntibody therapeutics2022
Novel development strategies and challenges for anti-Her2 antibody-drug conjugates.
Xinling Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it
ReviewAntibody therapeutics2022
Xinling Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.